These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10987348)
1. beta-blockers reduce the incidence of cardiac events in post-myocardial infarction patients. Ishikawa K; Miyataka M; Kanamasa K; Hayashi T; Takenaka T; Inoki T; Katayama K; Kimura A; Yabushita H; Kitayama K; Taniwa T; Nakano A Jpn Heart J; 2000 May; 41(3):279-94. PubMed ID: 10987348 [TBL] [Abstract][Full Text] [Related]
2. Beta-blockers prevent cardiac events in Japanese patients with myocardial infarction. Ishikawa K; Miyataka M; Kimura A; Takeda N; Hirano Y; Hayashi T; Kanamasa K; Circ J; 2004 Jan; 68(1):59-67. PubMed ID: 14695467 [TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis showing less cardiac events in post-myocardial infarction patients treated with metoprolol. Secondary Prevention Group. Ishikawa K; Miyataka M; Kanamasa K; Hayashi T; Takenaka T; Inoki T; Katayama K; Kimura A; Yabushita H; Kitayama K Jpn Circ J; 2000 May; 64(5):358-64. PubMed ID: 10834451 [TBL] [Abstract][Full Text] [Related]
4. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Hjalmarson A Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948 [TBL] [Abstract][Full Text] [Related]
5. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction. Heller DA; Ahern FM; Kozak M Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343 [TBL] [Abstract][Full Text] [Related]
6. Postinfarction use of beta-blockers in elderly patients. Aronow WS Drugs Aging; 1997 Dec; 11(6):424-32. PubMed ID: 9413700 [TBL] [Abstract][Full Text] [Related]
8. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of cardiac events by beta-blocking agents in elderly patients after myocardial infarction]. Ishikawa K; Kanamasa K; Hama J; Ogawa I; Takenaka T; Kimura A; Katori R Nihon Ronen Igakkai Zasshi; 1997 Apr; 34(4):273-7. PubMed ID: 9212681 [TBL] [Abstract][Full Text] [Related]
11. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623 [TBL] [Abstract][Full Text] [Related]
12. The role of beta-blockers in preventing sudden death in heart failure. Teerlink JR; Massie BM J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095 [TBL] [Abstract][Full Text] [Related]
13. Prevention of sudden cardiac death with beta blockers. Hjalmarson A Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter? Hjalmarson A Basic Res Cardiol; 2000; 95 Suppl 1():I41-5. PubMed ID: 11192352 [TBL] [Abstract][Full Text] [Related]
15. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes. McDonald CG; Majumdar SR; Mahon JL; Johnson JA Diabetes Care; 2005 Sep; 28(9):2113-7. PubMed ID: 16123475 [TBL] [Abstract][Full Text] [Related]
17. Beta-blocker underuse in secondary prevention of myocardial infarction. Everly MJ; Heaton PC; Cluxton RJ Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768 [TBL] [Abstract][Full Text] [Related]
18. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Singh BN Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400 [TBL] [Abstract][Full Text] [Related]
19. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Otterstad JE; Ford I Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391 [TBL] [Abstract][Full Text] [Related]
20. Beta-blockers for coronary heart disease in chronic kidney disease. Chonchol M; Benderly M; Goldbourt U Nephrol Dial Transplant; 2008 Jul; 23(7):2274-9. PubMed ID: 18187497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]